This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02648/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02648/identifier/pubchem-substance/
foafhttp://xmlns.com/foaf/0.1/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02648/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n17http://linked.opendata.cz/resource/drugbank/drug/DB02648/identifier/chemspider/
n6http://www.rxlist.com/cgi/generic/
n18http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n16http://linked.opendata.cz/resource/drugbank/drug/DB02648/identifier/chebi/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/drugbank/drug/DB02648/identifier/kegg-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02648/identifier/pdb/

Statements

Subject Item
n2:DB02648
rdf:type
n3:Drug
n3:description
Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. [PubChem]
n3:group
experimental
owl:sameAs
n8:DB02648 n18:DB02648
dcterms:title
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium
adms:identifier
n10:46504891 n11:152 n13:10918 n14:DB02648 n15:C00487 n16:17126 n17:83
foaf:page
n6:carnitor.htm
n3:IUPAC-Name
n4:271B4B1E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4B24-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4B23-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4B20-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4B21-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4B22-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4B1C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4B1D-363D-11E5-9242-09173F13E4C5 n4:271B4B1A-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4B1B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4B2A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4B2B-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4B25-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4B26-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4B28-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4B27-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4B29-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
461-06-3
n3:Bioavailability
n4:271B4B30-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4B32-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4B33-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4B2F-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4B2E-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4B31-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4B1F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4B2C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4B2D-363D-11E5-9242-09173F13E4C5